|
98
|
282
|
3smeA |
Structure of ptp1b inactivated by h2o2/bicarbonate |
|
91
|
287
|
3s3kA |
Crystal structure of the catalytic domain of ptp10d from drosophila melanogaster with a small molecular inhibitor para-nitrocatechol sulphate |
|
95
|
287
|
3s3fA |
Crystal structure of the catalytic domain of ptp10d from drosophila melanogaster with a small molecule inhibitor vanadate |
|
96
|
287
|
3s3eA |
Crystal structure of the catalytic domain of ptp10d from drosophila melanogaster |
|
95
|
287
|
3s3hA |
Crystal structure of the catalytic domain of ptp10d from drosophila melanogaster with a phosphopeptide substrate gp4 |
|
96
|
282
|
5qfwA |
Pandda analysis group deposition -- crystal structure of ptp1b in complex with compound_fmooa000497a |
|
95
|
282
|
5qfaA |
Pandda analysis group deposition -- crystal structure of ptp1b in complex with compound_xst00000752b |
|
140
|
534
|
5xzrA |
The atomic structure of shp2 e76a mutant in complex with allosteric inhibitor 9b |
|
98
|
282
|
5qe9A |
Pandda analysis group deposition -- crystal structure of ptp1b in complex with compound_fmopl000232a |
|
62
|
159
|
3ro1A |
Crystal structure of the complex of the archaeal sulfolobus ptp-fold phosphatase with terpyridine platinum(ii) |
|
92
|
282
|
5qfjA |
Pandda analysis group deposition -- crystal structure of ptp1b in complex with compound_fmsoa000814b |
|
176
|
586
|
2nlkA |
Crystal structure of d1 and d2 catalytic domains of human protein tyrosine phosphatase gamma (d1+d2 ptprg) |
|
110
|
300
|
5t19A |
Structure of ptp1b complexed with n-(3'-(1,1-dioxido-4-oxo-1,2,5-thiadiazolidin-2-yl)-4'-methyl-[1,1'-biphenyl]-4-yl)acetamide |
|
97
|
287
|
5ovxA |
X-ray characterization of striatal-enriched protein tyrosine phosphatase inhibitors |
|
99
|
287
|
5ovrA |
X-ray characterization of striatal-enriched protein tyrosine phosphatase inhibitors |
|
98
|
287
|
5ow1A |
X-ray characterization of striatal-enriched protein tyrosine phosphatase inhibitors |
|
105
|
289
|
5ka8A |
Protein tyrosine phosphatase 1b l192a mutant, open state |
|
106
|
299
|
5ka9A |
Protein tyrosine phosphatase 1b l192a mutant in complex with tcs401, open state |
|
101
|
298
|
5j8rA |
Crystal structure of the catalytic domain of human protein tyrosine phosphatase non-receptor type 12 - k61r mutant |
|
47
|
156
|
5k22A |
Crystal structure of the complex between human prl-2 phosphatase in reduced state and bateman domain of human cnnm3 |
|
100
|
280
|
5ka2A |
Protein tyrosine phosphatase 1b yaya (y152a, y153a) mutant, open state |
|
45
|
152
|
5k24A |
Crystal structure of the complex between phosphatase prl-2 in the oxidized state with the bateman domain of murine magnesium transporter cnnm3 |
|
108
|
300
|
5hdeA |
Crystal structure of ptpn12 catalytic domain |
|
160
|
522
|
5ibsA |
Structure of e76q, a cancer-associated mutation of the oncogenic phosphatase shp2 |
|
99
|
293
|
5awxA |
Crystal structure of human ptprz d1 domain |
|
95
|
293
|
5h08A |
Human ptprz d1 domain complexed with naz2329 |
|
107
|
297
|
4zrtA |
Ptp1bc215s bound to nephrin peptide substrate |
|
156
|
522
|
5ehrA |
Non-receptor protein tyrosine phosphatase shp2 in complex with allosteric inhibitor shp099 |
|
163
|
523
|
5ehpA |
Non-receptor protein tyrosine phosphatase shp2 in complex with allosteric inhibitor shp836 |
|
102
|
282
|
4yaaA |
Yoph w354y yersinia enterocolitica ptpase apo form |
|
105
|
297
|
4y14A |
Structure of protein tyrosine phosphatase 1b complexed with inhibitor (ptp1b:cpt157633) |
|
97
|
279
|
4s0gA |
Crystal structure of ptpn3 (ptph1) in complex with eps15 ptyr849 p850v peptide |
|
91
|
283
|
4ri4A |
Crystal structure of ptpn3 (ptph1) y676i mutant in complex with vanadate |
|
96
|
280
|
4qumA |
Crystal structure of ptpn3 (ptph1) in complex with a dually phosphorylated mapk12 peptide |
|
91
|
282
|
4rh9A |
Crystal structure of ptpn3 (ptph1) h812f, m883g mutant in complex with eps15 ptyr849 peptide |
|
98
|
283
|
4qunA |
Crystal structure of the ptpn3 (ptph1) catalytic domain c842s mutant |
|
91
|
282
|
4rhgA |
Crystal structure of ptpn3 (ptph1) d811e, c842s mutant in complex with eps15 ptyr849 peptide |
|
95
|
284
|
4ri5A |
Crystal structure of ptpn3 (ptph1) d811e mutant in complex with metavanadate |
|
89
|
280
|
4rh5A |
Crystal structure of ptpn3 (ptph1) in complex with eps15 ptyr849 peptide |
|
83
|
267
|
4rddA |
Co-crystal structure of shp2 in complex with a cefsulodin derivative |
|
82
|
275
|
4pvgA |
Crystal structure of protein tyrosine phosphatase shp2 catalytic domain complex with small molecular compound l88n79 |
|
104
|
299
|
4qahA |
The second sphere residue t263 is important for function and activity of ptp1b through modulating wpd loop |
|
97
|
298
|
4qbeA |
The second sphere residue t263 is important for function and activity of ptp1b through modulating wpd loop |
|
109
|
299
|
4qbwA |
The second sphere residue t263 is important for function and activity of ptp1b through modulating wpd loop |
|
104
|
299
|
4qapA |
The second sphere residue t263 is important for function and activity of ptp1b through modulating wpd loop |
|
158
|
526
|
4ohiA |
Leopard syndrome-associated shp2/q510e mutant |
|
144
|
524
|
4ohlA |
Leopard syndrome-associated shp2/t468m mutant |
|
158
|
531
|
4nwfA |
Crystal structure of the tyrosine phosphatase shp-2 with n308d mutation |
|
154
|
526
|
4oheA |
Leopard syndrome-associated shp2/g464a mutant |
|
150
|
526
|
4ohhA |
Leopard syndrome-associated shp2/q506p mutant |
